At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
Venus Vivadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles
In Brief
A clinical study evaluating Venus Viva for Acne Scars - Mixed Atrophic and Hypertrophic and Wrinkle. Completed, enrolled 10 participants across 1 site.
Detailed Summary
The objective of this clinical study is to evaluate the efficacy of fractional RF for the treatment and reduction of acne scarring or facial wrinkles.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedAug 2019
Enrollment StartAug 2019
Primary CompletionMar 2020
TodayJul 2026
First PostedAug 15, 2019
Enrollment StartAug 19, 2019
Primary CompletionMar 3, 2020
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.9 years ago
Interventions
Venus Vivadevice
The Venus Viva™ fractional RF device has been shown in clinical studies to improve various skin conditions related to aging and alter collagen structures such as wrinkles, rhytids and scars.